J 2021

Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis

PAZDERNIK, Michal; Helena BEDANOVA; Zhi CHEN; Josef KAUTZNER; Vojtech MELENOVSKY et al.

Základní údaje

Originální název

Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis

Autoři

PAZDERNIK, Michal; Helena BEDANOVA; Zhi CHEN; Josef KAUTZNER; Vojtech MELENOVSKY; Ivan MALEK; Antonij SLAVCEV; Michaela BARTONOVA; Vladimir KARMAZIN; Tomas ECKHARDT; Ales TOMASEK; Eva OZÁBALOVÁ; Tomas KOVARNIK; Peter WOHLFAHRT a Milan SONKA

Vydání

Transplant Immunology, Amsterdam, ELSEVIER, 2021, 0966-3274

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30213 Transplantation

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.032

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/21:00122148

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Cardiac allograft vasculopathy; Donor specific antibodies; Heart transplant; Intimal thickness

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 8. 2021 08:58, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Recent studies suggested potential positive correlations between HLA-specific antibodies and development of cardiac allograft vasculopathy (CAV). Methods: This prospective two-center study investigated early progression of CAV by coronary optical coherence tomography in 1 month and 12 months after heart transplantation (HTx) in 104 patients. Detection and characterization of donor specific (DSA) and MHC class-I polypeptide-related sequence A (MICA) antibodies were performed before, 1, 6 and 12 months after transplantation. Results: During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area (P < .001), and progression in mean intimal thickness (IT) (P < .001). DSA and anti-MICA occurred in 17% of all patients, but no significant relationship was observed between presence of DSA/anti-MICA and IT progression within 12 months after HTx. In contrast, we observed significant association between presence of DSA (p=0.031), de-novo DSA (p=0.031), HLA Class II DSA (p=0.017) and media thickness (MT) progression. Conclusion: Results of our study did not identify a direct association between presence of DSA/anti-MICA and intimal thickness progression in an early period after HTx. However, we found significant relationships between DSA and media thickness progression that may identify a newly recognized immune-pathological aspect of CAV.